<?xml version="1.0" encoding="UTF-8"?>
<ref id="B16-pharmaceuticals-12-00060">
 <label>16.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ferreira</surname>
    <given-names>A.C.</given-names>
   </name>
   <name>
    <surname>Zaverucha-do-Valle</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Reis</surname>
    <given-names>P.A.</given-names>
   </name>
   <name>
    <surname>Barbosa-Lima</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Vieira</surname>
    <given-names>Y.R.</given-names>
   </name>
   <name>
    <surname>Mattos</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>de Silva</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Sacramento</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>de Castro Faria Neto</surname>
    <given-names>H.C.</given-names>
   </name>
   <name>
    <surname>Campanati</surname>
    <given-names>L.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae</article-title>
  <source>Sci. Rep.</source>
  <year>2017</year>
  <volume>7</volume>
  <fpage>9409</fpage>
  <pub-id pub-id-type="doi">10.1038/s41598-017-09797-8</pub-id>
  <pub-id pub-id-type="pmid">28842610</pub-id>
 </element-citation>
</ref>
